The Singapore Bioimaging Consortium (SBIC) aims to build a coordinated national programme for imaging research, bringing together substantial strengths in the physical sciences and engineering and those in the biomedical sciences. SBIC seeks to identify and consolidate the various bioimaging capabilities across local research institutes, universities and hospitals in order to speed the development of biomedical research discoveries.
SBIC's intramural programme comprises 9 research units, namely the Magnetic Resonance Imaging Group (MRIG*), Translational Molecular Imaging Group (TMIG*), Magnetic Resonance Spectroscopy and Metabolic Imaging (MRS/MI*) Group, PET Chemistry Group (PCG*), Bio-optical Imaging Group (BOIG*), Mechanistic Systems-biology NMR Group (MSNG*), Lab of Metabolic Medicine (LMM), Fat Metabolism and Stem Cell Group (FMSCG), Lab of Bioimaging Probe Development (LBPD), Biomedical Imaging Lab (BIL), and Quantitative Image Processing Group (QIPG). *MRIG, TMIG, MRS/MI Group, PCG, MSNG, and BOIG are collectively called the Lab of Molecular Imaging (LMI). More >>